Compliance Cul-de-Sac? Terrascope and the Missing Route for Bona Fide Business Pivots

[Vighnesh is a student at National Law University Odisha.]

Allotment of shares on a preferential basis offers speed and discretion in targeting strategic investors. When a listed entity raises funds through preferential allotment, it must disclose the intended use of those funds. These disclosures are the basis on which investors and market participants make buy, hold, or sell decisions.

Historically, the disclosure obligations emerged through a combination of company law and securities regulation. Section 173 of the Companies Act 1956, which was replaced by Section 102 of the Companies Act 2013, required explanatory statements. In parallel with Regulation 73 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2009, specific disclosure requirements were introduced for preferential issues. The problem remained that the framework did not have strict enforcement; it was treated as a formality. As well as, such formality was restricted to potential/interested allottees only. This changes when, in a watershed moment, the Supreme Court in SEBI v. Terrascope Ventures (Terrascope), permanently reshaped this formality into an obligation, which cannot be casually altered or bypassed.

The court held that disclosures made in an EGM notice for preferential allotment by a listed company are not merely internal corporate statements. They are disclosures to the market, with consequences that cannot be cured by subsequent shareholder approval where the underlying conduct amounts to illegality. However, while Terrascope clarifies what companies cannot do, it also exposes a regulatory gap: the law does not provide a clear mechanism for bona fide modification of disclosed objects when commercial circumstances genuinely change. This creates a grey area where good-faith business decisions may risk being treated similarly to fraudulent diversions. That silence is the problem this post addresses.

What the Law Required before Terrascope

The pre-Terrascope framework did not entirely lack mechanisms for variation, but these were confined to specific fundraising contexts. Section 27 of the Companies Act 2013 provides a structured process for variation of objects in a prospectus-based offer, including shareholder approval and an exit opportunity. However, this mechanism is limited to public issues and does not extend to preferential allotments or private placements.

In contrast, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2009 required listed companies undertaking preferential issues to disclose the objects of the issue in the explanatory statement accompanying the EGM notice, but did not provide a comparable mechanism for post-disclosure variation of those objects.

This absence of a variation mechanism created a regulatory grey area. The amicus curiae in Terrascope argued for applying Section 27 by analogy, but the court rejected this argument. In practice, the assumption appeared to be that since preferential allotments involved identified investors, subsequent corrective action or ratification by those investors could cure any deviation. Terrascope rejected that approach.

What Terrascope Decided and Why it is Right

The Supreme Court rejected the private-contract argument and placed market integrity at the centre of its reasoning. The core holding is that EGM disclosures by a listed company cannot be treated as internal memoranda because they are capable of influencing market information and investor decision-making.

First, in the facts of Terrascope, diversion of funds from disclosed objects to undisclosed objects was treated as falling within the insider trading framework, since the disclosures in the EGM notice were market-facing representations capable of influencing investor decisions and market conduct.

Second, the court emphasised the public-law dimension of the insider trading regulations. It held that post-facto ratification cannot serve as a defence for an act that is void ab initio. The protections under the insider trading regulations extend to the entire securities market. A private resolution among shareholders cannot operate as a waiver permitting the company or its shareholders to bypass the law. As the court stated, “there cannot be a ratification of illegality.”

Although preferential allotments are directed at identified investors, disclosures made in an EGM notice do not affect only the allottees. They enter the public domain and may contribute to price discovery and investment decisions in the secondary market. It is this broader impact that justifies treating such disclosures as operating beyond purely private relationships.

The deployment in question was also beyond the company’s objects clause at the relevant time. This brought the doctrine of ultra vires into play and provided an additional reason why shareholder ratification could not cure the defect.

Both aspects of the holding are correct and welcome. By recognising that such disclosures have implications beyond the immediate parties, the court ensured that transparency remains central to market regulation. Further, by holding that an act illegal from inception cannot be ratified merely because shareholders voting on the resolution approve or condone the diversion, the court strengthened the public-interest foundation of securities regulation.

The Gap the Judgment Leaves Unaddressed

The judgment addresses fraudulent diversion, but leaves unresolved the position of companies acting in good faith. Consider a company that raises funds for a stated acquisition. After the EGM notice but before deployment of funds, the acquisition becomes unviable because of changed market conditions, regulatory rejection, or other commercial developments. The company is then left holding funds for an object that no longer exists or no longer makes commercial sense. Which lawful route remains available?

A clearer distinction is necessary. At least three categories of conduct must be separated. First, there are cases of fraudulent diversion, where the company never intended to deploy funds for the disclosed object. These rightly attract liability. Second, there are cases of bona fide commercial change, where the disclosed object was genuine when stated, but later became impossible, unlawful, or commercially irrational. Third, there are cases of opportunistic deviation, where the original object remains viable, but the company seeks to use the funds for a different or more attractive purpose.

Terrascope effectively addresses the first category. The regulatory gap arises primarily in relation to the second category, and to a limited extent in relation to the third. Section 27 cannot be used in this context, as the court expressly held. As a result, a company undertaking a preferential allotment is left without a clear lawful mechanism to redirect funds where the disclosed object has genuinely failed, while any deviation may invite scrutiny under the insider trading regulations.

The more significant question, therefore, is not whether Terrascope was correctly decided. It was. The question is what route remains available when commercial circumstances genuinely change after disclosure.

What a Workable Framework Should Look Like

The Supreme Court has identified the limits of post-facto ratification. The next task is to build a procedural framework that permits bona fide course correction without compromising market integrity. Such a framework must distinguish between companies acting in good faith and those attempting fraudulent or opportunistic diversion.

Any workable regulatory framework must accommodate bona fide commercial changes while ensuring that opportunistic deviations are subject to heightened scrutiny and fraudulent diversions remain prohibited. A possible model could draw from the logic of Section 27, while being adapted to preferential allotments. This may be implemented through a SEBI circular or regulatory amendment establishing a prior-disclosure and approval mechanism for material variations in the objects of a preferential issue. The framework should define the circumstances that trigger a mandatory variation process. These may include abandonment of the original object, diversion to a different line of activity, or circumstances rendering the original disclosed object unviable.

Where a material change occurs, the company should be required to obtain shareholder approval by special resolution. To protect market integrity and the interests of investors who relied on the previous disclosure, dissenting shareholders may be given an exit option in appropriate cases. The framework may also include limited safe-harbour criteria, such as drastic regulatory or macroeconomic changes, to distinguish bona fide variations from opportunistic deviations.

The missing element is a principled basis to distinguish deliberate fraudulent diversion from genuine commercial necessity. Timing and conduct may be relevant indicators, but a formal mechanism is needed so that courts and regulators are not left to infer intent only after the fact. Once the mechanism is triggered, the company should issue a fresh EGM notice and make stock-exchange disclosures setting out the reasons for the proposed variation, the revised utilisation of funds, the associated risk factors, and the circumstances necessitating the change. Any revised use must fall within the company’s objects clause or be preceded by a valid alteration of that clause. The proposed variation should also be supported by board authorisation, and in appropriate cases by certification from independent directors, confirming that the original object has become impossible, unviable, or commercially irrational, and that the proposed variation is in the company’s interest.

Regulatory oversight may operate on a tiered basis. Ordinary variations may proceed through disclosure and shareholder approval, while significant deviations may require SEBI review or approval.

These suggestions do not undermine Terrascope. Rather, they provide a procedural mechanism through which transparency and commercial flexibility can coexist.

Conclusion

Terrascope settles an important question and should be welcomed for reinforcing transparency as a foundational norm of securities regulation. By refusing to allow shareholder approval to cure market-facing illegality, the court reaffirmed informational integrity as a central principle of the securities market.

However, the judgment identifies what companies cannot do without resolving what they may do when disclosed objects later become commercially unviable. That unresolved issue requires regulatory attention. The court is right that transparency at inception is non-negotiable. The framework must now ensure that transparency is also the answer when reality changes and disclosed plans no longer work after they have been proposed.